Cork Cancer Research Centre's photostream  

Cork Cancer Research Centre (CCRC) is dedicated to bringing new cancer treatments to patients and focuses on breast, colon, kidney, leukaemia, oesophageal and prostate cancers. Our research programmes are aimed at providing less invasive procedures for cancer surgery, decreasing recovery times for patients and making surgery possible where it is presently considered unsuitable.

Investment in research is vital if we wish to develop new therapies in the areas of cancer prevention, detection and treatment. Through well focused research we strongly believe that a great number of lives can be saved and the quality of life for many people who develop this disease can be improved.

The CCRC does not have any source of annual state funding and therefore is extremely reliant on the voluntary fundraising efforts made by the public and the success of our fundraisers for our continued existence. This momentum provides the drive and encouragement for breakthroughs to be made and for improvements to be made in the quality of life for all cancer patients.

It is sad that there are still so many families affected by this disease even now. However, we are confident that the work we are doing at the Cork Cancer Research Centre will change that and offer real hope to patients. With three unique clinical trials to date, we are bringing research to where it is needed most, the patients.


Why Is Cancer Research Important?
•1 in 3 people will be diagnosed with cancer in their lifetime.
•The number of cancers diagnosed in Ireland is expected to double by 2020.
•An increase will occur in almost all cancer types, mostly as a result of population ageing, but also as a result of an increase in underlying incidence rates for most cancers.

Cancer Treatment As It Stands Today:
•Surgery remains the only treatment option most likely to lead to long term survival for patients diagnosed with early stage disease.
•Pharmacotherapy provides brief and unpredictable responses in patients whose disease is diagnosed at a more advanced stage… the majority of patients fall into this category.
•Once a tumour has metastasised to secondary locations, the chances of a curative treatment drop significantly.